Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
Christopher Pasquale

Christopher Pasquale Analyst Performance

Senior Analyst at Barclays

Christopher Pasquale is a stock analyst at Barclays focused in the healthcare sector, covering 23 publicly traded companies. Over the past year, Christopher Pasquale has issued 29 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Christopher Pasquale's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Christopher Pasquale's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
38 Last 9 Years
Buy Recommendations
57.89% 22 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy23.7%9 ratings
Buy34.2%13 ratings
Hold36.8%14 ratings
Sell5.3%2 ratings

Out of 38 total stock ratings issued by Christopher Pasquale at Barclays, the majority (36.8%) have been Hold recommendations, followed by 34.2% Buy, 23.7% Strong Buy, and 5.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
65.2% of companies on NASDAQ
15 companies
NYSE
34.8% of companies on NYSE
8 companies

Christopher Pasquale, an analyst at Barclays, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
22 companies
95.7%
Industrials
1 company
4.3%

Christopher Pasquale of Barclays specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
21 companies
91.3%
BIOTECHNOLOGY
1 company
4.3%
PROFESSIONAL SERVICES
1 company
4.3%

Christopher Pasquale's Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
AxoGen, Inc. stock logo
AXGN
AxoGen
10/23/2026Lower Price Target$36.68$50.00Overweight
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
10/21/2026Reiterated Rating$438.00$500.00Overweight
MiniMed Group Inc stock logo
MMED
MiniMed Group
10/7/2026Initiated Coverage$19.64$22.00Equal Weight
Senseonics Holdings, Inc. Common Stock stock logo
SENS
Senseonics Holdings, Inc. Common Stock
10/7/2026Initiated Coverage$9.96$10.00Equal Weight
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
10/7/2026Initiated Coverage$80.28$120.00Overweight
Alcon stock logo
ALC
Alcon
10/7/2026Upgrade$62.96Hold
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
10/7/2026Upgrade$17.34Strong-Buy
Boston Scientific Corporation stock logo
BSX
Boston Scientific
10/7/2026Upgrade$41.55Hold
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
10/7/2026Upgrade$54.75Hold
DexCom, Inc. stock logo
DXCM
DexCom
10/7/2026Upgrade$84.30Strong-Buy
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
10/7/2026Upgrade$85.62Strong-Buy
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
10/7/2026Upgrade$64.67Strong-Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
10/7/2026Upgrade$0.47Hold
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
10/7/2026Upgrade$414.52Strong-Buy
LivaNova PLC stock logo
LIVN
LivaNova
10/7/2026Upgrade$75.93Strong-Buy
Medtronic PLC stock logo
MDT
Medtronic
10/7/2026Upgrade$85.51Hold
Insulet Corporation stock logo
PODD
Insulet
10/7/2026Upgrade$134.36Hold
Stryker Corporation stock logo
SYK
Stryker
10/7/2026Upgrade$275.17Strong-Buy
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
10/7/2026Upgrade$15.84Hold
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
10/7/2026Upgrade$88.42Hold
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
10/6/2026Initiated Coverage$56.43$60.00Positive
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
10/6/2026Initiated Coverage$17.51$30.00Overweight
Medtronic PLC stock logo
MDT
Medtronic
10/6/2026Initiated Coverage$87.01$95.00Equal Weight
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
10/6/2026Initiated Coverage$68.12$65.00Underweight
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
10/6/2026Initiated Coverage$18.63$30.00Overweight
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
10/6/2026Initiated Coverage$17.21$24.00Overweight
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
10/6/2026Upgrade$17.43Strong-Buy
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
10/6/2026Upgrade$66.50Strong Sell
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
10/6/2026Upgrade$17.90Strong-Buy